» Articles » PMID: 30856482

Down-regulation of Hepatitis Delta Virus Super-infection in the Woodchuck Model

Overview
Journal Virology
Specialty Microbiology
Date 2019 Mar 12
PMID 30856482
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Mechanisms mediating clearance of hepatitis delta virus (HDV) are poorly understood. This study analyzed in detail profound down-regulation of HDV infection in the woodchuck model. Super-infection with HDV of woodchucks chronically infected with HBV-related woodchuck hepatitis virus produced two patterns. In the first, HDV viremia had a sharp peak followed by a considerable decline, and initial rise of HDV virions' infectivity followed by abrupt infectivity loss. In the second, HDV titer rose and later displayed plateau-like profile with high HDV levels; and HDV infectivity became persistently high when HDV titer reached the plateau. The infectivity loss was not due to defects in the virions' envelope, binding to anti-envelope antibodies, or mutations in HDV genome, but it correlated with profound reduction of the replication capacity of virion-associated HDV genomes. Subsequent finding that in virions with reduced infectivity most HDV RNAs were not full-length genomes suggests possible HDV clearance via RNA fragmentation.

Citing Articles

Sera of Individuals Chronically Infected with Hepatitis B Virus (HBV) Contain Diverse RNA Types Produced by HBV Replication or Derived from Integrated HBV DNA.

Zaiets I, Gunewardena S, Menne S, Weinman S, Gudima S J Virol. 2023; 97(3):e0195022.

PMID: 36877036 PMC: 10062156. DOI: 10.1128/jvi.01950-22.


Multiple Regions Drive Hepatitis Delta Virus Proliferation and Are Therapeutic Targets.

Zi J, Gao X, Du J, Xu H, Niu J, Chi X Front Microbiol. 2022; 13:838382.

PMID: 35464929 PMC: 9022428. DOI: 10.3389/fmicb.2022.838382.


In Vivo Models of HDV Infection: Is Humanizing NTCP Enough?.

Giersch K, Dandri M Viruses. 2021; 13(4).

PMID: 33807170 PMC: 8065588. DOI: 10.3390/v13040588.

References
1.
Wedemeyer H . Hepatitis D revival. Liver Int. 2011; 31 Suppl 1:140-4. DOI: 10.1111/j.1478-3231.2010.02408.x. View

2.
Tsai J, Margolis H, Jeng J, Ho M, Chang W, Hsieh M . Immunoglobulin- and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis B virus infection. Clin Immunol Immunopathol. 1998; 86(3):246-51. DOI: 10.1006/clin.1997.4477. View

3.
Yurdaydin C . Treatment of chronic delta hepatitis. Semin Liver Dis. 2012; 32(3):237-44. DOI: 10.1055/s-0032-1323629. View

4.
Kim S, Lee S, Choi I, Shin J, Uhm J, Kim S . Circulating immune complexes and cell-mediated immunity in patients with hepatitis B virus associated liver diseases. Yonsei Med J. 1990; 31(4):347-58. DOI: 10.3349/ymj.1990.31.4.347. View

5.
Chang J, Gudima S, Tarn C, Nie X, Taylor J . Development of a novel system to study hepatitis delta virus genome replication. J Virol. 2005; 79(13):8182-8. PMC: 1143748. DOI: 10.1128/JVI.79.13.8182-8188.2005. View